Comprehensive Master Guide to S4 (Andarine): Molecular Architecture, Partial Agonism Dynamics, and Wholesale Supply

In the sophisticated landscape of advanced biochemical research, endocrinology studies, and cutting-edge pharmaceutical development, Selective Androgen Receptor Modulators (SARMs) have transformed the paradigm of non-steroidal ligand design. Traditional anabolic-androgenic agents have long presented researchers with a significant pharmacological paradox: while they successfully promote skeletal muscle hypertrophy and osteogenic activity, their lack of tissue specificity frequently induces undesirable off-target systemic side effects, particularly in prostate, cardiovascular, and sebaceous tissues.

To overcome these structural limitations, modern medicinal chemistry engineered a new class of non-steroidal ligands designed to selectively activate androgen receptors in targeted tissues while sparing others. Among this elite group of experimental molecules, S4 (Andarine) stands out as one of the most structurally unique, historically significant, and thoroughly investigated aryl propionamide SARMs in modern scientific literature.

At Wholesale China Peptides, we pride ourselves on being a premier global supplier of certified research compounds, raw materials, and professional-grade specialized solutions. Whether your laboratory is engaged in advanced chromatographic analysis, endocrine receptor binding assays, or large-scale B2B distribution, understanding the structural science, precise composition, pharmacokinetic profile, and synthesis standards of S4 (Andarine) is essential for maintaining absolute experimental accuracy.

In this comprehensive, exhaustive technical guide, we will dive deep into the molecular architecture, chemical properties, pharmacodynamics, ocular binding anomalies, physical traits, formulation standards, and wholesale availability of S4 (Andarine).

---

1. What is S4 (Andarine)?

S4 (Andarine) is an orally active, non-steroidal Selective Androgen Receptor Modulator originally developed by GTx, Inc. as an investigative treatment for benign prostatic hypertrophy (BPH), muscle wasting, and age-related sarcopenia.

To fully appreciate the significance of S4 (Andarine) in laboratory research, one must understand its developmental position within the history of S4/SARM chemistry. As one of the earliest aryl propionamide-derived SARMs to undergo extensive preclinical and early-stage clinical evaluation, S4 (Andarine) established many of the baseline structural principles that govern modern tissue-selective drug design.

Unlike conventional testosterone replacement therapies and synthetic anabolic steroids that stimulate androgen receptors uniformly across every tissue type in the body, S4 (Andarine) was engineered specifically to decouple these systemic effects—exhibiting high anabolic activity in skeletal muscle and bone tissue while demonstrating a partial agonist profile in reproductive and secondary tissues.

Because of its unique non-steroidal chemical scaffold, S4 (Andarine) does not share the classic four-ring cyclopentanoperhydrophenanthrene structure of traditional steroidal hormones. Yet, it achieves an extraordinarily high binding affinity and excellent oral bioavailability, making it a premier subject of study in myogenesis, body composition modeling, and targeted receptor pharmacology.

---

2. Comprehensive Chemical Information and Composition

Formulating a stable, high-purity batch of S4 (Andarine) requires absolute precision in organic synthesis, stereochemical control, and analytical verification. Whether supplied as raw crystalline powder or prepared as a standardized research solution, understanding its exact chemical identity is paramount for laboratory quality control.

Molecular and Chemical Specifications:

• International Nonproprietary Name / Research Identifier: S-4, Andarine, GTx-007
• IUPAC Chemical Name: 3-(4-nitro-3-trifluoromethylphenyl)-N-(iso-propyl)-2-hydroxy-2-methylpropanamide
• Base Chemical Formula: C19H18F3N3O3C19​H18​F3​N3​O3​
• Molecular Weight: 441.36 g/mol (or 393.36 g/mol depending on free base vs salt configuration; typically synthesized as the pure chiral amide yielding ~441.36 g/mol when factoring in specific substitutions).
• Purity Standards: Exceeding 99% verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).
• Physical State: Fine crystalline powder, white to pale yellow in color.

Core Structural Features

The chemical architecture of S4 (Andarine) is characterized by an aryl propionamide core structure featuring a bicalutamide-derived hydantoin skeleton replacement. Specifically, it consists of a substituted nitro-trifluoromethylphenyl group linked to an optically active propionamide backbone containing an isopropyl amide tail.

This unique non-steroidal configuration was discovered through rigorous structure-activity relationship (SAR) optimization studies designed to maximize anabolic potency while eliminating the structural elements responsible for unwanted side effects.

The presence of the nitro (NO2NO2​) and trifluoromethyl (CF3CF3​) functional groups creates strong electrostatic and hydrophobic interactions within the ligand-binding domain of the androgen receptor. Furthermore, the specific stereochemistry (the chiral center at the 2-position of the propanamide chain) is vital; altering this spatial orientation dramatically reduces the compound’s binding affinity, underscoring the necessity of high-purity synthesis and stringent stereochemical control.

---

3. Mechanism of Action: Partial Agonism and Receptor Dynamics

The primary scientific interest surrounding S4 (Andarine) lies in its precise pharmacodynamic interaction with androgen receptors across different organ systems, specifically its classification as a partial agonist.

Receptor Binding and Anabolic Activation

When S4 (Andarine) enters systemic circulation, it crosses cellular membranes and binds specifically to androgen receptors (ARs) located in target tissues. Upon binding, the SARM undergoes conformational changes that recruit specific co-activator proteins while discouraging the recruitment of co-repressors.

This selective recruitment initiates gene transcription pathways that drive protein synthesis, nitrogen retention, and cellular hypertrophy primarily in skeletal muscle and osteogenic (bone) cells. In standard in vitro and in vivo binding assays, S4 (Andarine) demonstrates an exceptionally high relative binding affinity for the AR—measuring with a dissociation constant (KiKi​) that allows it to compete aggressively with endogenous androgens.

The Partial Agonist Phenomenon

Unlike full agonists (such as testosterone or certain fully optimized SARMs like LGD-4033) which maximize receptor activation to 100% capacity upon binding, S4 (Andarine) functions as a partial agonist.

• Skeletal Muscle & Bone: In skeletal muscle and bone tissue, this partial activation is more than sufficient to trigger robust anabolic pathways, leading to measurable increases in muscle mass and enhanced bone mineral density.
• Prostate & Reproductive Tissues: Because it is a partial agonist, when S4 (Andarine) binds to androgen receptors in prostate tissue—where maximal stimulation is required for full hypertrophy—it acts essentially as a functional antagonist in the presence of stronger androgens, or simply fails to trigger the maximal signaling cascade. This results in significantly lower prostate weight stimulation compared to traditional anabolic steroids. This differential activation profile makes S4 (Andarine) an invaluable model for studying targeted anabolic therapy without systemic hypertrophy of the prostate.

Absence of Aromatization

Because S4 (Andarine) is a non-steroidal compound lacking the steroid nucleus entirely, it possesses zero chemical affinity for the aromatase enzyme. It cannot convert into estrogen under any metabolic circumstances. Consequently, experimental models utilizing S4 (Andarine) will never experience estrogenic side effects, providing a pristine environment for studying pure androgen receptor signaling.

---

4. Pharmacokinetics and Systemic Dynamics (Including Ocular Binding)

Understanding the pharmacokinetic profile of S4 (Andarine) is essential for designing accurate experimental protocols and analytical assays. Furthermore, S4 (Andarine) possesses a unique pharmacokinetic quirk that has fascinated pharmacologists for decades: its interaction with ocular receptors.

Oral Bioavailability and Absorption

Due to its stable non-steroidal chemical scaffold, S4 (Andarine) exhibits excellent oral bioavailability. It resists rapid degradation in the gastrointestinal tract and enters systemic circulation efficiently following oral ingestion. In laboratory settings, it is frequently dissolved in polar organic solvents such as DMSO, polyethylene glycol (PEG), or high-purity ethanol for liquid experimental distribution.

Plasma Half-Life and Dosing Frequency

The terminal elimination half-life of S4 (Andarine) is relatively short, ranging between 4 to 6 hours.

Unlike long-acting SARMs that require only a single daily administration, the short half-life of S4 (Andarine) necessitates split-dosing protocols (typically administered twice daily in experimental frameworks) to maintain stable, uninterrupted plasma concentrations and continuous androgen receptor occupancy throughout a 24-hour cycle.

The Ocular Binding Phenomenon (Yellow Vision)

One of the most widely documented and studied characteristics of S4 (Andarine) in scientific literature is its mild, reversible affinity for binding to androgen receptors located within the eyes—specifically binding to receptors in the rod cells of the retina.

• The Biochemical Mechanism: At higher systemic concentrations, S4 (Andarine) exhibits a minor cross-reactivity with ocular proteins, temporarily altering the eye’s ability to adjust to rapid changes in light.
• Experimental Manifestation: In laboratory subjects and clinical observations, this manifests as a yellowish tint to the field of vision (xanthopsia) or difficulty adjusting vision when transitioning from brightly lit environments to low-light or nighttime settings.
• Reversibility: This phenomenon is strictly dose-dependent and entirely transient. Upon cessation of administration or adjustment of dosage thresholds, the binding clears rapidly, and normal ocular function and color perception return to baseline without permanent tissue damage. For researchers studying receptor cross-reactivity and off-target binding affinities, S4 (Andarine) serves as an exceptional case study in ligand selectivity limits.

---

5. Key Research Applications and Investigative Frameworks

In the realm of advanced biochemical and endocrinological research, S4 (Andarine) is investigated across a wide spectrum of physiological models:

• Myogenesis and Muscle Hypertrophy Models: Researchers frequently utilize S4 (Andarine) in catabolic wasting models (such as cancer cachexia or age-related sarcopenia simulations) to study its ability to stimulate muscle protein synthesis, enhance nitrogen balance, and prevent muscle atrophy without inducing systemic toxicity.
• Osteoporosis and Bone Mineralization: Due to its robust anabolic action on osteoblasts, S4 (Andarine) is studied extensively in bone fracture healing and osteoporosis models to evaluate improvements in bone mineral density, cortical thickness, and structural integrity.
• Lipid Metabolism and Fat Oxidation: Preclinical studies have noted that S4 (Andarine) exhibits unique interactions with lipoprotein lipase and lipid-clearing pathways, making it a frequent subject of study in metabolic rate adjustments, visceral fat reduction, and body composition repartitioning.
• Receptor Selectivity and Off-Target Binding Studies: Because of its partial agonist profile and well-documented ocular cross-reactivity, S4 (Andarine) is utilized extensively in computational pharmacology and medicinal chemistry to model how minor structural modifications can alter off-target tissue affinity.

---

6. Physical Properties and Quality Control Standards

For laboratory technicians, analytical chemists, and wholesale buyers, recognizing the physical characteristics and quality control benchmarks of high-purity S4 (Andarine) is critical for experimental validation:

• Appearance: A fine, crystalline powder, ranging from white to pale yellow in color (when supplied as raw API) or a clear, homogenous solution (when compounded into research liquids). It should be entirely free from discoloration, clumping, or foreign particulate matter.
• Solubility: Insoluble in water; highly soluble in polar organic solvents such as DMSO (Dimethyl sulfoxide), Ethanol, and Polyethylene Glycol (PEG 400), making it exceptionally easy to reconstitute for laboratory assays and liquid research formulations.
• Storage Recommendations: Store dry powder in a cool, dark environment (controlled room temperature between 20°C to 25°C) protected from moisture and direct UV light. Reconstituted liquid solutions should be kept refrigerated (2°C to 8°C) to maintain long-term molecular stability.
• Analytical Verification: Every production lot of S4 (Andarine) supplied by Wholesale China Peptides undergoes mandatory High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing to verify that molecular identity, isomeric purity, and overall purity levels exceed 99%.

---

7. Why Source S4 (Andarine) from Wholesale China Peptides?

Navigating the global marketplace for advanced research chemicals, raw SARMs, and specialized peptide solutions requires an uncompromising commitment to supply chain integrity. Inferior synthesis, incorrect stereochemistry, or contaminated powders can compromise months of laboratory research and invalidate chromatographic data.

When you partner with Wholesale China Peptides for your S4 (Andarine) supply needs, you gain access to an elite tier of B2B manufacturing excellence:

• Certified Laboratory Purity: All our raw powders and formulated solutions are backed by verifiable HPLC and MS certificates of analysis, ensuring absolute precision in molecular structure, chiral purity, and overall purity exceeding 99%.
• Advanced Synthesis & Quality Assurance: Produced in state-of-the-art chemical synthesis environments utilizing strict stereochemical control, rigorous crystallization techniques, and comprehensive batch testing.
• Secure, Discrete Global Logistics: We understand the sensitive nature of international research supply chains. Our specialized packaging solutions are engineered to protect delicate compounds, maintain thermal stability, and ensure seamless customs clearance worldwide.
• Scalable Wholesale Pricing: Whether you are an independent research institution, a compounding laboratory, or a large-scale distributor, our direct-to-consumer B2B pricing structures offer unmatched economic value without ever compromising on quality.

---

8. Frequently Asked Questions (FAQs)

1. What makes S4 (Andarine) different from full agonist SARMs like LGD-4033?

While full agonist SARMs maximize androgen receptor activation to 100% capacity in target tissues, S4 (Andarine) functions as a partial agonist. This means it stimulates anabolic pathways in skeletal muscle and bone sufficiently to drive tissue accretion while acting as a functional antagonist in reproductive tissues, resulting in lower prostate stimulation.

2. What causes the unique “yellow vision” side effect associated with S4 (Andarine)?

The transient visual phenomenon (xanthopsia or altered night vision adaptation) occurs because S4 (Andarine) exhibits a minor, dose-dependent cross-reactivity with androgen receptors located in the rod cells of the human retina. This side effect is entirely dose-dependent, temporary, and reverses immediately upon reducing dosage or discontinuing administration.

3. What is the active half-life of S4 (Andarine) in research models?

The terminal elimination half-life of S4 (Andarine) is relatively short, ranging between 4 to 6 hours. Due to this short half-life, experimental protocols typically utilize split-dosing (administered twice daily) to maintain stable, continuous plasma concentrations.

4. How can I place a wholesale order for S4 (Andarine)?

You can review our product catalog, examine batch specifications, and place secure bulk wholesale orders directly through our official platform at https://wholesalechinapeptides.com/. For specialized custom synthesis, bulk institutional pricing, or specific HPLC documentation requests, please reach out directly to our customer support and sales engineering team.

---

Conclusion

The exploration of advanced selective receptor modulators requires meticulous adherence to chemical purity, precise stereochemical control, and uncompromising manufacturing standards. S4 (Andarine) remains an unrivaled, essential benchmark for modern biochemical research, endocrinology studies, and partial agonist investigations where targeted tissue selectivity and unique receptor cross-reactivity are required.

Trust Wholesale China Peptides as your premier B2B partner for certified research compounds, advanced SARMs, and specialized formulations. Visit our website today to explore our comprehensive inventory, review our analytical testing reports, and secure your high-purity S4 (Andarine) supply.